Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jun Wang, M.D.
Peking University People's Hospital
Principal Investigator - Lin Xu, M.D.
Jiang Su Cancer Hospital
Study Director - Yilong Wu, M.D.
Guang Dong General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peking University People'S Hospital
Beijing, Beijing Municipality, China
Fan Yang, M.D.Jun Wang, M.D.Kezhong Chen, M.D.Lixin Zhou, M.D. - Guang Dong General Hospital, Thoracic Surgery
Guangzhou, Guangdong, China
Wenzhao Zhong, M.D.Xuening Yang, M.D.Yilong Wu, M.D. - Jiang Su Cancer Hospital
Nanjing, Jiangsu, China
Feng Yin, M.D.Lin Xu, M.D.
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2018
- Primary completion
- 31 Dec 2021
- Completion
- 31 Dec 2021
- Last update posted
- 21 May 2018
- Registered enrollment
- 145
- Registry id
- NCT02696525
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.